|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-10-9
|
|
pubmed:abstractText |
The aim of this study was to evaluate the efficacy and toxicity of gemcitabine combined with irinotecan in patients with previously treated non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
547-51
|
|
pubmed:meshHeading |
pubmed-meshheading:16870693-Adult,
pubmed-meshheading:16870693-Aged,
pubmed-meshheading:16870693-Anemia,
pubmed-meshheading:16870693-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16870693-Camptothecin,
pubmed-meshheading:16870693-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16870693-Deoxycytidine,
pubmed-meshheading:16870693-Drug Administration Schedule,
pubmed-meshheading:16870693-Female,
pubmed-meshheading:16870693-Humans,
pubmed-meshheading:16870693-Leukopenia,
pubmed-meshheading:16870693-Lung Neoplasms,
pubmed-meshheading:16870693-Male,
pubmed-meshheading:16870693-Middle Aged,
pubmed-meshheading:16870693-Nausea,
pubmed-meshheading:16870693-Platinum,
pubmed-meshheading:16870693-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.
|
|
pubmed:affiliation |
Thoracic Oncology Center, Cancer Institute Hospital, Koto-ku, Tokyo 135-8550, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
